Covered recipient · General Payments record
MATTHEW C LAWRENCE
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$6,827.96
- Reported across 381 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $591.02 | 30 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $238.79 | 14 |
| Amgen Inc. | $81.25 | 3 |
| SANOFI PASTEUR INC. | $48.62 | 1 |
| Exact Sciences Corporation | $42.06 | 2 |
| GlaxoSmithKline, LLC. | $36.95 | 2 |
| Novo Nordisk AS | $35.64 | 2 |
| PFIZER INC. | $35.47 | 2 |
| Lilly USA, LLC | $32.33 | 2 |
| Lundbeck LLC | $22.71 | 1 |
| Acerta Pharma LLC | $17.20 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (30)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $32.12 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104144278 | CMS |
| ABBVIE INC. | $20.65 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104144280 | CMS |
| ABBVIE INC. | $22.30 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104144282 | CMS |
| ABBVIE INC. | $22.22 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104144284 | CMS |
| ABBVIE INC. | $17.87 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104144286 | CMS |
| ABBVIE INC. | $24.00 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104144288 | CMS |
| ABBVIE INC. | $26.02 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104144290 | CMS |
| ABBVIE INC. | $12.23 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104144292 | CMS |
| ABBVIE INC. | $6.02 | 04/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104144294 | CMS |
| ABBVIE INC. | $6.15 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104144296 | CMS |
| ABBVIE INC. | $17.54 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104144298 | CMS |
| ABBVIE INC. | $11.13 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104144300 | CMS |
| ABBVIE INC. | $7.98 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104144302 | CMS |
| ABBVIE INC. | $12.56 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104144304 | CMS |
| Amgen Inc. | $25.56 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117306638 | CMS |
| Amgen Inc. | $26.47 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115854446 | CMS |
| Amgen Inc. | $29.22 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117306640 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.20 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105725673 | CMS |
| Exact Sciences Corporation | $16.47 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114750397 | CMS |
| Exact Sciences Corporation | $25.59 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114750402 | CMS |
| GlaxoSmithKline, LLC. | $20.12 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116340682 | CMS |
| GlaxoSmithKline, LLC. | $16.83 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116027150 | CMS |
| Lilly USA, LLC | $15.48 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135206206 | CMS |
| Lilly USA, LLC | $16.85 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135197506 | CMS |
| Lundbeck LLC | $22.71 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145938180 | CMS |
| Novo Nordisk Inc | $22.31 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096880051 | CMS |
| Novo Nordisk Inc | $13.33 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097811959 | CMS |
| PFIZER INC. | $19.35 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131168732 | CMS |
| PFIZER INC. | $16.12 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132003946 | CMS |
| SANOFI PASTEUR INC. | $48.62 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128738468 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.